Also known as hgh 176-191
A weight-loss research peptide. Current market pricing by vial size, and vendor listings as they are verified.
For research use only. Not for human consumption. No health, dosing, or usage claims are made.
HGH Fragment 176-191 is a synthetic peptide corresponding to the C-terminal region of human growth hormone. It is not an FDA-approved drug and is sold only as a research chemical.
This is the C-terminal fragment of human growth hormone (residues 176-191); on-file CAS 66004-57-7 matches PubChem. It differs from AOD-9604, which carries an extra N-terminal tyrosine.
Regulatory status: As of 2026, HGH Fragment 176-191 is not FDA-approved for any use and is not listed on the FDA 503A Category 2 bulk-substances list.
Typical vendor vial prices, Jul 2026. Exact prices load with verified listings.
| Vendor | Vial price | |
|---|---|---|
Simple Peptide | $0.05Best | View vendor › |
Precision Research Peptides | $0.13 | View vendor › |
Prime Lab Peptides | $0.16 | View vendor › |
Koi Peptides | $0.18 | View vendor › |
Protide Health | $0.20 | View vendor › |
BioInfinity Lab | $0.22 | View vendor › |
Kaia Peptides | $0.33 | View vendor › |
BioLongevity Labs | $0.50 | View vendor › |
Mile High Compounds | $1 | View vendor › |
PSPeptides | $3.60 | View vendor › |
Skye Peptides | $8.80 | View vendor › |
Examined in cell and animal models of lipid metabolism; this reflects laboratory research and not a demonstrated effect in people.
Planning a reconstitution? Use the calculator — it is math for handling a vial, not dosing.
Sources & further reading: PubChem CID 16131230 (NCBI)
How we source this ›